The Varieties of Religious Experience: 263.
Penguin Classics, 1983
(first edition 1902).
National Collaborating Centre for Mental Health.
Alcohol-Use Disorders. Diagnosis, Assessment and Management of
Harmful Drinking and Alcohol Dependence
. NICE Clinical Guideline 115.
British Psychological Society & Royal College of
Miller, WR, Wilbourne, PL.
Mesa Grande: a methodological analysis of clinical trials of
treatments for alcohol use disorders.
2002; 97: 265–77.
Home Office. The Government's Alcohol Strategy. Cm
8336. TSO (The Stationery
Hickman, M, Carnwath, Z, Madden, P, Farrell, M, Rooney, C, Ashcroft, R, et al.
Drug-related mortality and fatal overdose risk: pilot cohort
study of heroin users recruited from specialist drug treatment sites in
London. J Urban Health
2003; 80: 274–87.
Connock, M, Juarez-Garcia, A, Jowett, S, Frew, E, Liu, Z, Taylor, RJ, et al.
Methadone and buprenorphine for the management of opioid
dependence: a systematic review and economic evaluation.
Health Technol Assess
World Health Organization Regional Office for Europe.
The European Tobacco Control Report 2007.
Reus, VI, Smith, BJ.
Multimodal techniques for smoking cessation: a review of
their efficacy and utilisation and clinical practice
guidelines. Int J Clin Pract
2008; 62: 1753–68.
Psychedelic Psychiatry: LSD from Clinic to Campus.
Johns Hopkins University Press,
Dr Leary's Concord Prison experiment: a 34-year follow-up
study. Psychoactive Drugs
1998; 30: 419–26.
Hendricks, PS, Clark, CB, Johnson, MW, Fontaine, KR, Cropsey, KL.
Hallucinogen use predicts reduced recidivism among
substance-involved offenders under community corrections
supervision. J Psychopharmacol
2014; 28: 62–6.
MacLean, KA, Johnson, MW, Griffiths, RR.
Mystical experiences occasioned by the hallucinogen
psilocybin lead to increases in the personality domain of
openness. J Psychopharmacol
2011; 25: 1453–61.
The use of hallucinogens in the treatment of
addiction. Addiction Res
1996; 4: 177–89.
Bogenschutz, MP, Pommy, JM.
Therapeutic mechanisms of classic hallucinogens in the
treatment of addictions: from indirect evidence to testable
hypotheses. Drug Test Anal
2012; 4: 543–55.
Krupitsky, EM, Grinenko, AY.
Ketamine psychedelic therapy (KPT): a review of the results
of ten years of research. J Psychoactive
1997; 29: 165–83.
Shaping the renaissance of psychedelic
2012; 380: 200–1.